Publications & Documents


  • 4-December-2017

    English

    Environmental biosafety

    Most OECD countries and many non-members have a system of regulatory oversight for products of modern biotechnology (genetically-engineered /transgenic organisms) which are intended for release to the environment. The OECD biosafety work programme aims to consider all types of organisms (plants, trees, animals, micro-organisms) and to promote international harmonisation.

    Related Documents
  • 30-November-2017

    English

    Neurotechnology and society: Strengthening responsible innovation in brain science

    This report identifies, and seeks to address, key challenges for the responsible development of neurotechnology. In particular, it analyses frameworks and mechanisms for integrating social concerns in the early development of technology, and discusses best practices for research funders across the public and private sector.

    Related Documents
  • 22-November-2017

    English

    OECD Science, Technology and Industry Scoreboard 2017 - The digital transformation

    With some 200 indicators, the 2017 edition of the OECD Science, Technology and Industry (STI) Scoreboard shows how the digital transformation affects science, innovation, the economy, and the way people work and live. It aims to help governments design more effective science, innovation and industry policies in the fast-changing digital era.

    The charts and underlying data in this publication are available for download and over half the indicators contain additional data expanding the time and/or country coverage of the print edition.

  • 21-November-2017

    English

    Scientometrics

    This page provides relevant information on OECD work on scientometrics and bibliometrics. This field has has evolved over time from the study of indices for improving information retrieval from peer-reviewed scientific publications (commonly described as the “bibliometric” analysis of science) to cover other types of documents and information sources relating to science and technology.

    Related Documents
  • 21-November-2017

    English

    ANBERD (Analytical Business Enterprise Research and Development) database

    Data set on R&D expenditure by industry which addresses the problems of international comparability and breaks in the time series of the official business enterprise R&D data.

    Related Documents
  • 17-November-2017

    English

    What role for social sciences in innovation? Re-assessing how scientific disciplines contribute to different industries

    Commonly used data and methodologies offer only partial perspectives on science-industry linkages. This policy paper offers new insights to better capture the contributions of social scientists and the complex disciplinary needs of the digital economy.

    Related Documents
  • 17-November-2017

    English

    Innovation statistics and indicators

    The OECD has played a key role in the development of international guidelines for surveys of business innovation and the design of indicators constructed with data from such surveys. In addition to developing methodological guidance, the OECD also carries out analytical studies using innovation-related indicators and microdata.

    Related Documents
  • 14-November-2017

    English

    Measuring Tax Support for R&D and Innovation

    Governments worldwide increasingly rely on tax incentives in addition to direct support measures (e.g. grants) to promote R&D in firms and encourage innovation and economic growth. The OECD has developed experimental methodologies and a detailed database on R&D tax incentives with the latest indicators on the cost and information on the design and scope of R&D tax incentives.

    Related Documents
  • 9-November-2017

    English

    Key nanotechnology indicators

    Indicators include nanotech firms, nanotech R&D, public sector R&D expenditure and nanotechnology patents.

    Related Documents
  • 9-November-2017

    English

    Key biotechnology indicators

    Statistics on biotechnology firms, biotechnology R&D (including public sector expenditures), biotech applications and patents.

  • << < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65 | 66 | 67 | 68 | 69 | 70 | 71 > >>